Back to Journals » OncoTargets and Therapy » Volume 17

Case Series

Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

       
Total article views   HTML views PDF downloads Totals
1,501 Dovepress* 1,501+ 25 1,526
Totals 1,501 25 1,526
*Since 29 March 2024
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar